US Sexually Transmitted Diseases (STD) Diagnostics Market
Size, Share & Trends Analysis Report by Forecast Period
2019-2025
US STD diagnostics market is growing at a CAGR of around 8.1% during the forecast period.
The major aspects that are making considerable contributing towards its high market share
include the fact that the country emphasizes more towards increasing the efficiency with the
effectiveness of the treatment of various diseases including STDs. Further, the rapidly
developed healthcare infrastructure and significant government healthcare spending are
promoting R&D of such advanced technology across the country thereby promoting the growth
of the US STD diagnostics market.
Get Free Sample link @ https://www.omrglobal.com/request-sample/us-sexually-
transmitted-disease-market
According to the Research America, the US had spent $182.3 billion in R&D of medical and
healthcare and several investments were made by the foundations, industries, Federal agencies
and others. The federal agencies had invested more than $35.9 million along with National
Institute of Health that comprises $29.6 billion share. There was several spending that the US
healthcare and medical had received for research and development R&D activities.
A full report of US Sexually Transmitted Diseases (STD) Diagnostics Market
available @ https://www.omrglobal.com/industry-reports/us-sexually-transmitted-
disease-market
Market Coverage
Market number available for – 2019-2025
Base year- 2019
Forecast period- 2020-2025
Segment Covered- By Source, By Product Type, By Applications
Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc,
Cargill Inc., and others
Market Segmentation
US STD Diagnostics Market by Disease Type
o Chlamydia
o Syphilis
o Gonorrhea
o Herpes Simplex Virus (HSV)
o Human Papilloma Virus (HPV)
o Human Immunodeficiency Virus (HIV)
o Others
US STD Diagnostics Market by Product
o Laboratory Testing Devices
o Point-of-Care (POC) Testing Devices
US ST